Healthcare
Live Price
Offline$0.0016
+0.00% today
1Y Change
+45.45%
Window
Jun 23, 2025 → May 29, 2026
Coverage: 236 bars · Jun 23, 2025 → May 29, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Carepay Inc. (SOFE) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 45.5% across the available one-year price window (Jun 23, 2025 → May 29, 2026). Baseline metrics include revenue growth of +372.2%, EPS growth of +2120.0%, a dividend yield of 0.0%. What stands out right now is revenue +372.2%, EPS +2120.0%, free cash flow +7571.5% with operating margin 27.1% and ROIC 40.0%. Valuation is more restrained than many high-expectation growth names at P/E 0.1 and price/sales 0.0. Overall, the current profile looks closer to a quality compounder than a generic broad-market placeholder. Stock Foundry combines SOFE price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SOFE
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SOFE Max Drawdown
-81.82%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SOFE and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$2.0M
+620.6% YoY
FY Net Income
-$277.8K
+78.8% YoY
Free Cash Flow
-$658.2K
+36.0% YoY
Revenue Growth
+372.2%
EPS Growth
+2120.0%
Gross Margin
27.1%
Net Margin
21.4%
Income statement
USD
| Metric | 2022 | 2021 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|
| Revenue | 1M | 310K | 0 | 278K | 2M |
| Gross Profit | 397K | 94K | -5K | 234K | 2M |
| Operating Income | 397K | 83K | -1M | -2M | -650K |
| EBITDA | -369 | -736 | -527K | -1M | -466K |
| Net Income | 313K | 13K | -977K | -1M | -278K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2022 | 2021 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|
| Cash & Equivalents | 442K | 21K | 17K | 332K | 285K |
| Total Assets | 4M | 3M | 70K | 4M | 4M |
| Total Liabilities | 3M | 3M | 1M | 7M | 6M |
| Shareholder Equity | 756K | 443K | -970K | -3M | -3M |
| Total Debt | 28K | 28K | 63K | 3M | 2M |
| Net Debt | -415K | 6K | 46K | 3M | 2M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
435K
+0.4% YoY
Capital Expenditures
223K
+62.2% YoY
Free Cash Flow
658K
+36.0% YoY
Key ratios
Gross Margin
27.1%
Operating Margin
27.1%
Net Margin
21.4%
ROE
52.2%
Debt / Equity
0.04x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.